BBIO logo

BridgeBio Pharma (BBIO) Enterprise Value

Enterprise Value

$7.48 B
-$128.51 M-1.69%

27 min ago


Summary


Performance

BBIO Enterprise Value Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

OtherBBIOvaluationmetrics:

Enterprise Value Formula

Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents

BBIO Enterprise Value Trends

PeriodPeriodEnterprise valueEnterprise valueMarket capMarket capPricePrice
todaytoday-1.7%-2.1%-2.1%
1 m1 month+7.8%+9.8%+9.8%
3 m3 months+17.2%+22.4%+22.4%
6 m6 months+28.7%+33.9%+33.3%
ytdytd+12.9%+16.5%+16.5%
1 y1 year+2.9%+1.9%-5.6%
5 y5 years+84.5%+39.1%-9.0%

BBIO Enterprise Value Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month-11.7%$6.94 B+7.8%
3 m3-month$8.48 B-11.7%$5.73 B+30.5%
6 m6-month$8.48 B-11.7%$5.73 B+30.5%
1 y1-year$8.48 B-11.7%$5.57 B+34.4%
3 y3-year$8.89 B-15.8%$2.13 B+252.0%
5 y5-year$11 B-31.4%$1.72 B+334.6%
alltimeall time$11 B-31.4%$1.72 B+334.6%

BridgeBio Pharma Enterprise Value History

DateValue
2025
$7.48 B(+12.9%)
2024
$6.63 B(-21.8%)
2023
$8.47 B(+240.0%)
DateValue
2022
$2.49 B(-34.3%)
2021
$3.79 B(-57.3%)
2020
$8.88 B(+118.5%)
2019
$4.06 B

FAQ

  • What is BridgeBio Pharma enterprise value?
  • What is the all time high enterprise value for BridgeBio Pharma?
  • What is BBIO enterprise value year-to-date change?
  • What is BridgeBio Pharma enterprise value year-on-year change?

What is BridgeBio Pharma enterprise value?

The current enterprise value of BBIO is $7.48 B

What is the all time high enterprise value for BridgeBio Pharma?

BridgeBio Pharma all-time high enterprise value is $10.91 B

What is BBIO enterprise value year-to-date change?

BridgeBio Pharma enterprise value has changed by +$854.23 M (+12.89%) since the beginning of the year

What is BridgeBio Pharma enterprise value year-on-year change?

Over the past year, BBIO enterprise value has changed by +$211.55 M (+2.91%)